Cigarette Experimentation and the Population Attributable Fraction for Associated Genetic and Non-Genetic Risk Factors

Anna V. Wilkinson, Michael D. Swartz, Xiaoying Yu, Margaret R. Spitz, Sanjay Shete

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: We, and others, have shown that experimenting with cigarettes is a function of both non-genetic and genetic factors. In this analysis we ask: how much of the total risk of experimenting with cigarettes, among those who had not experimented with cigarettes when they enrolled in a prospective cohort, is attributable to genetic factors and to non-genetic factors? Methods: Participants (N = 1,118 Mexican origin youth), recruited from a large population-based cohort study in Houston, Texas, provided prospective data on cigarette experimentation over three years. Non-genetic data were elicited twice - baseline and follow-up. Participants were genotyped for 672 functional and tagging variants in the dopamine, serotonin and opioid pathways. Results: In the overall model, the adjusted combined non-genetic PAF was 71.2% and the adjusted combined genetic PAF was 58.5%. Among committed never smokers the adjusted combined non-genetic PAF was 67.0% and the adjusted combined genetic PAF was 53.5%. However, among cognitively susceptible youth, the adjusted combined non-genetic PAF was 52.0% and the adjusted combined genetic PAF was 68.4%. Conclusions: Our results suggest there may be differences in genotypes between youth who think they will try cigarettes in the future compared to their peers who think they will not and underscore the possibility that the relative influence of genetic vs. non-genetic factors on the uptake of smoking may vary between these two groups of youth. Impact: A clearer understanding of the relative role of genetic vs. non-genetic factors in the uptake of smoking may have implications for the design of prevention programs.

Original languageEnglish (US)
Article numbere53868
JournalPLoS One
Volume8
Issue number1
DOIs
StatePublished - Jan 16 2013
Externally publishedYes

Fingerprint

cigarettes
Tobacco Products
risk factors
Population
Smoking
Opioid Analgesics
Dopamine
Serotonin
Cohort Studies
narcotics
peers
Genotype
dopamine
cohort studies
serotonin
genotype

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Cigarette Experimentation and the Population Attributable Fraction for Associated Genetic and Non-Genetic Risk Factors. / Wilkinson, Anna V.; Swartz, Michael D.; Yu, Xiaoying; Spitz, Margaret R.; Shete, Sanjay.

In: PLoS One, Vol. 8, No. 1, e53868, 16.01.2013.

Research output: Contribution to journalArticle

Wilkinson, Anna V. ; Swartz, Michael D. ; Yu, Xiaoying ; Spitz, Margaret R. ; Shete, Sanjay. / Cigarette Experimentation and the Population Attributable Fraction for Associated Genetic and Non-Genetic Risk Factors. In: PLoS One. 2013 ; Vol. 8, No. 1.
@article{d81e6dd042034c3e8613a9d3ef23d3a8,
title = "Cigarette Experimentation and the Population Attributable Fraction for Associated Genetic and Non-Genetic Risk Factors",
abstract = "Background: We, and others, have shown that experimenting with cigarettes is a function of both non-genetic and genetic factors. In this analysis we ask: how much of the total risk of experimenting with cigarettes, among those who had not experimented with cigarettes when they enrolled in a prospective cohort, is attributable to genetic factors and to non-genetic factors? Methods: Participants (N = 1,118 Mexican origin youth), recruited from a large population-based cohort study in Houston, Texas, provided prospective data on cigarette experimentation over three years. Non-genetic data were elicited twice - baseline and follow-up. Participants were genotyped for 672 functional and tagging variants in the dopamine, serotonin and opioid pathways. Results: In the overall model, the adjusted combined non-genetic PAF was 71.2{\%} and the adjusted combined genetic PAF was 58.5{\%}. Among committed never smokers the adjusted combined non-genetic PAF was 67.0{\%} and the adjusted combined genetic PAF was 53.5{\%}. However, among cognitively susceptible youth, the adjusted combined non-genetic PAF was 52.0{\%} and the adjusted combined genetic PAF was 68.4{\%}. Conclusions: Our results suggest there may be differences in genotypes between youth who think they will try cigarettes in the future compared to their peers who think they will not and underscore the possibility that the relative influence of genetic vs. non-genetic factors on the uptake of smoking may vary between these two groups of youth. Impact: A clearer understanding of the relative role of genetic vs. non-genetic factors in the uptake of smoking may have implications for the design of prevention programs.",
author = "Wilkinson, {Anna V.} and Swartz, {Michael D.} and Xiaoying Yu and Spitz, {Margaret R.} and Sanjay Shete",
year = "2013",
month = "1",
day = "16",
doi = "10.1371/journal.pone.0053868",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Cigarette Experimentation and the Population Attributable Fraction for Associated Genetic and Non-Genetic Risk Factors

AU - Wilkinson, Anna V.

AU - Swartz, Michael D.

AU - Yu, Xiaoying

AU - Spitz, Margaret R.

AU - Shete, Sanjay

PY - 2013/1/16

Y1 - 2013/1/16

N2 - Background: We, and others, have shown that experimenting with cigarettes is a function of both non-genetic and genetic factors. In this analysis we ask: how much of the total risk of experimenting with cigarettes, among those who had not experimented with cigarettes when they enrolled in a prospective cohort, is attributable to genetic factors and to non-genetic factors? Methods: Participants (N = 1,118 Mexican origin youth), recruited from a large population-based cohort study in Houston, Texas, provided prospective data on cigarette experimentation over three years. Non-genetic data were elicited twice - baseline and follow-up. Participants were genotyped for 672 functional and tagging variants in the dopamine, serotonin and opioid pathways. Results: In the overall model, the adjusted combined non-genetic PAF was 71.2% and the adjusted combined genetic PAF was 58.5%. Among committed never smokers the adjusted combined non-genetic PAF was 67.0% and the adjusted combined genetic PAF was 53.5%. However, among cognitively susceptible youth, the adjusted combined non-genetic PAF was 52.0% and the adjusted combined genetic PAF was 68.4%. Conclusions: Our results suggest there may be differences in genotypes between youth who think they will try cigarettes in the future compared to their peers who think they will not and underscore the possibility that the relative influence of genetic vs. non-genetic factors on the uptake of smoking may vary between these two groups of youth. Impact: A clearer understanding of the relative role of genetic vs. non-genetic factors in the uptake of smoking may have implications for the design of prevention programs.

AB - Background: We, and others, have shown that experimenting with cigarettes is a function of both non-genetic and genetic factors. In this analysis we ask: how much of the total risk of experimenting with cigarettes, among those who had not experimented with cigarettes when they enrolled in a prospective cohort, is attributable to genetic factors and to non-genetic factors? Methods: Participants (N = 1,118 Mexican origin youth), recruited from a large population-based cohort study in Houston, Texas, provided prospective data on cigarette experimentation over three years. Non-genetic data were elicited twice - baseline and follow-up. Participants were genotyped for 672 functional and tagging variants in the dopamine, serotonin and opioid pathways. Results: In the overall model, the adjusted combined non-genetic PAF was 71.2% and the adjusted combined genetic PAF was 58.5%. Among committed never smokers the adjusted combined non-genetic PAF was 67.0% and the adjusted combined genetic PAF was 53.5%. However, among cognitively susceptible youth, the adjusted combined non-genetic PAF was 52.0% and the adjusted combined genetic PAF was 68.4%. Conclusions: Our results suggest there may be differences in genotypes between youth who think they will try cigarettes in the future compared to their peers who think they will not and underscore the possibility that the relative influence of genetic vs. non-genetic factors on the uptake of smoking may vary between these two groups of youth. Impact: A clearer understanding of the relative role of genetic vs. non-genetic factors in the uptake of smoking may have implications for the design of prevention programs.

UR - http://www.scopus.com/inward/record.url?scp=84872468552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872468552&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0053868

DO - 10.1371/journal.pone.0053868

M3 - Article

C2 - 23342024

AN - SCOPUS:84872468552

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e53868

ER -